Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 32 citations in OpenAlex.

1. Presumed Cytokine-Mediated Mild Liver Injury With Similar Kinetics Following COVID-19, Acute Prostatitis, and mRNA Vaccination: A Case Report and Review of the Literature.Cureus · 2026
   Article
2. A Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue.Pharmaceutics · 2024
   Article
3. Protective Effects of PollenAid Plus Soft Gel Capsules' Hydroalcoholic Extract in Isolated Prostates and Ovaries Exposed to Lipopolysaccharide.Molecules (Basel, Switzerland) · 2022
   Article
4. Oral fosfomycin activity against Klebsiella pneumoniae in a dynamic bladder infection in vitro model.The Journal of antimicrobial chemotherapy · 2022
   Article
5. Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.Drugs · 2022
   Review
6. Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales.Antibiotics (Basel, Switzerland) · 2022
   Article
7. Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution.Prostate cancer and prostatic diseases · 2021
   Article
8. Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies.Antibiotics (Basel, Switzerland) · 2020
   Review
9. Management of Chronic Bacterial Prostatitis.Current urology reports · 2020
   Review
10. Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses againstAntimicrobial agents and chemotherapy · 2020
    Article
11. Pharmacological Interventions for Bacterial Prostatitis.Frontiers in pharmacology · 2020
    Review
12. Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland.Infection · 2019
    Article
13. Characteristics of febrile urinary tract infections in older male adults.BMC geriatrics · 2019
    Observational
14. Antimicrobial agents and chemotherapy · 2019
    Article
15. Oral fosfomycin for the treatment of chronic bacterial prostatitis.The Journal of antimicrobial chemotherapy · 2019
    Observational
16. Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows.Scientific reports · 2018
    Article
17. Treatment of extended-spectrum β-lactamase-producingF1000Research · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

3 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract